Chris Gugl work email
- Valid
- Valid
- Valid
Chris Gugl personal email
Chris has over 15 years of experience in healthtech and digital health as a pioneering entrepreneur. He has focused on innovation, brand building, and developing solutions with consistently positive outcomes. As a pragmatic leader, Chris excels in forming and scaling high-performing teams and startups. His understanding of patient and physician needs, coupled with keen market awareness, has led him to shape new business fields. Recognized with the Digital Shaper Awards, Chris remains committed to continuous learning and driving healthcare transformation. He contributes to clinical research and imparts knowledge as a lecturer at ETH Zurich.
-
Ceo And ChairmanEvoleen AgZurich, Switzerland
-
CeoEvoleen Ag Jun 2018 - PresentZürich, ChEvoleen transforms healthcare using healthtech, clinical excellence and co-creations to fight chronic diseases, ensure access to care and enable healthy aging, making a significant impact on everyone's life.
-
Lecturer In Mas Digital Clinical ResearchEth Zürich 2022 - PresentZürich, ChThe Master of Advanced Studies (MAS) ETH digital Clinical Research (MAS diCR) (https://mas-dicr.ethz.ch/) is a new continuing education programme at ETH. It is designed for physicians and other professionals who want to make a difference. It welcomes participants who are keen to learn more about the various facets of clinical research in the rapidly changing environment of new digital diagnostics and technologies in order to answer clinical research questions that employ patient-centric approaches and novel technologies. -
Co-Founder & InvestorDigehealth 2023 - PresentZurich, ChApproximately 10% of individuals with Crohn's disease experience recurrent obstructions, a condition associated with elevated mortality rates. This not only imposes a substantial global economic burden but also incurs an additional financial strain on patients. Recognizing the critical need for proactive intervention, DigeHealth has pioneered an innovative solution—an automatic 24/7 bowel monitoring system. This cutting-edge technology relies on a proprietary wearable, advanced sensor technology, and cloud-based artificial intelligence. By leveraging these components, DigeHealth aims to empower both Crohn's patients and their healthcare providers to intervene promptly, ultimately enhancing patient outcomes and reducing the economic impact of recurring obstructions. -
InvestorCitus Ag 2023 - PresentDübendorf, Zurich, ChMechanics play a key role in our everyday life. Soft tissues, as the skin, constantly touch, feel, and interact with our environment. Characterization of the tissue as a material thereby opens promising chances in improving life.Motivated by this, the project started in 2016 with the development of the first research prototype. Two successful trials followed shortly after, showing the safety and efficacy of this device. Further, they proved the ability of mechanical characterization on early detection of skin fibrosis and longitudinal monitoring of scar formation after burns.The project then took off with support of the ETH Zürich Pioneer Fellowship in 2021, a Innosuisse research grant in 2022 and the BRIDGE Proof of Concept in 2023. -
Co-Founder & InvestorAssureyou Gmbh 2023 - PresentAssureYou serves as the distributor for next-generation prenatal care solutions in Switzerland. Their offerings include a state-of-the-art remote ultrasound solution crafted specifically for the convenience of pregnant women and their gynecologists, allowing them to perform scans at home. This guided platform provides reassurance to expectant mothers and ensures the maintenance of high-quality care through the supervision and support of the treating gynecologist.
-
Co-Founder And Executive Board MemberAlbatross Care 2022 - PresentAlbatross holistically coordinates multiple drugs, significantly improving the therapeutic performance and quality of life of neuropathic pain patients, while allowing physicians to replace specific drugs with magistral drugs such as medicinal cannabis.
-
Co-FounderTherayou 2022 - PresentTherayou is a psychiatric clinic in Basel with a virtual clinic twin in the Metaverse, offering a blended care model of Face2Face and virtual therapy sessions with remote digital interventions and immersive experiences.
-
Co-Founder And Executive Board MemberSiva Health 2021 - PresentStadtkreis 3 Wiedikon, Zurich, ChSIVA is a digital health startup company in the field of sound-based respiratory diagnostics and collaborates with global corporate partners, researchers and clinics. SIVA's respiratory solution is a unique continuous ambulatory cough detector. It provides longitudinal 24/7 cough profiles and contextual data at high convenience for patients and doctors. The SIVA ambulatory cough detector contributes to a better understanding of cough - by collecting relevant data in clinical studies and by supporting diagnosis and therapy monitoring in clinical practice. -
Co-Founder And Executive Board MemberWings Health 2021 - PresentWINGS is indicated to improve the QoL, side-effects and the OS of cancer patients as well as to diagnose oncology depression in good time, based on a better understanding of their condition / their therapy as well as an active engagement of their social inner circle, which supports the patient in several dimensions.
-
Co-Founder And Executive Board MemberCarity 2021 - PresentSt. Gallen, ChCarity is a digital platform enabling the patient’s psychocardiological monitoring, engagement and coaching. It is introduced as well as actively used during cardiac rehabilitation and smoothly accompanies the patient afterwards. until his/her personal goal is reached. -
Co-Founder And Board MemberCollabree Ag 2020 - PresentZurich, Zh, ChCollabree is a digital adherence start-up focusing on improving therapy compliance of chronically ill patients by applying behavioral economics principles.https://www.collabree.com/ -
AdvisorPharmabiome Ag 2018 - 2020Zürich, ChPharmaBiome is a pre-clinical microbiome company that combines deep scientific expertise in microbiome microbiology, biotechnology and the molecular disease mechanisms. PharmaBiome have developed differentiated technologies based on the advanced scientific understanding of the science of the interdependent metabolic functions of host and microbiome. -
Head Of Integrated CareHelbling Technik Ag 2013 - May 2018Zurich, Ch -
Program ManagerAbbott 2010 - 2013Abbott Park, Illinois, Us -
Biomedical EngineerMedela Ag 2008 - 2010Baar, Zg, Ch -
Project ManagerUniversitätsspital Zürich 2007 - 2008Zürich, Zürich, Ch -
Senior InstructorEiselin Sport 2004 - 2008 -
Sales RepresentativeManor Ag 2001 - 2004Basel, Bs, Ch
Chris Gugl Skills
Chris Gugl Education Details
-
University Of St.GallenExecutive Mba -
Eth ZürichBiomedizintechnik/Medizintechnik
Frequently Asked Questions about Chris Gugl
What company does Chris Gugl work for?
Chris Gugl works for Evoleen Ag
What is Chris Gugl's role at the current company?
Chris Gugl's current role is CEO and Chairman.
What is Chris Gugl's email address?
Chris Gugl's email address is ch****@****ling.ch
What schools did Chris Gugl attend?
Chris Gugl attended University Of St.gallen, Eth Zürich.
What skills is Chris Gugl known for?
Chris Gugl has skills like Entrepreneurship, Unternehmensstrategie, Produktentwicklung, Projektmanagement, Forschung Und Entwicklung, Medical Devices, Produktmanagement, Unternehmensberatung.
Who are Chris Gugl's colleagues?
Chris Gugl's colleagues are Christoph Schröter, Sabrina García-Alfarè, Bartosz Wielek.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial